|
Aug 7
|
Is Athira Pharma (ATHA) Stock Outpacing Its Medical Peers This Year?
|
|
Jun 30
|
retail investors who own 35% along with institutions invested in Athira Pharma, Inc. (NASDAQ:ATHA) saw increase in their holdings value last week
|
|
Jun 3
|
We're A Little Worried About Athira Pharma's (NASDAQ:ATHA) Cash Burn Rate
|
|
May 15
|
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
|
|
May 7
|
Sidoti Events, LLC's Virtual May Micro-Cap Conference
|
|
May 2
|
Athira Pharma to Participate in Upcoming May Conferences
|
|
Apr 23
|
One Athira Pharma Insider Raised Their Stake In The Previous Year
|
|
Apr 15
|
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
|
|
Apr 11
|
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
|
|
Apr 3
|
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
|
|
Mar 29
|
Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?
|
|
Mar 8
|
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
|
|
Mar 1
|
Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year?
|
|
Feb 28
|
Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy?
|
|
Dec 5
|
Sidoti Events, LLC's Virtual December Small-Cap Conference
|
|
Nov 29
|
Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
|
|
Nov 28
|
Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND
|
|
Nov 15
|
Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer’s Disease
|
|
Nov 15
|
Athira Pharma Insiders Placed Bullish Bets Worth US$556.3k
|
|
Aug 10
|
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
|